March 17, 2023 10:48 AM EDT
News Briefing

Ipsen re­ceives new palo­varotene PDU­FA date; Ac­er halts de­vel­op­ment of ex-Sanofi drug

Tyler Patchen

News Reporter

Kyle LaHucik

Senior Reporter

The FDA will be giv­ing Ipsen an­oth­er shot at ap­proval for one of its can­di­dates.

Ipsen an­nounced that the FDA has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times